Funding profile · Cellular agriculture

Brown Foods

One disclosed seed round of $2.36 million from June 2022, no Form D, no federal grants, and a stated plan to reach US retail in 2026. The capital record is thinner than the product record, and the product record is one test tube.

Data as of September 23, 2026. Company-reported figures are labeled.

Rounds at a glance

What the filings show

Reading the filings

1. The absence of a Form D is informative, but only up to a point.Regulation D offerings require a Form D within 15 days of first sale. Brown Foods has none. Issuers raising under Section 4(a)(2) file nothing at all, so the gap does not prove no money moved. It does mean no offering size, no investor count and no related persons exist on the public record for any Brown Foods round.
2. The company’s own total went down, not up.June 2022 reporting put the seed at $2.36 million. The February 2025 release states $2.3 million raised to date. Rounding explains the difference, but the direction is the point: between June 2022 and February 2025 the company claimed no new capital at all. Thirty two months, one round.
3. Four years on one seed is the central financial fact.$2.36 million raised in mid 2022, two operating sites, mammalian cell culture with its media costs, and a stated 2026 retail launch. A cell culture company running four years on that is either burning very little, or has taken capital it has not announced and has not filed for.
4. There is no non-dilutive money.No NIH award, no NSF SBIR, no federal grant of any kind was found. That removes the one funding source that normally leaves an auditable paper trail of technical milestones.
5. Cheese before milk is a cost signal.AgFunder, a seed investor, writes on its portfolio page that the process eliminates cells from the final product, reducing costs, and that the company “is launching with cheese and will expand to milk as costs decline.” Cheese takes roughly ten litres of milk per kilogram and sells at many times the price of fluid milk per litre of input, so it absorbs a high unit cost that fluid milk cannot. Entering with cheese says the cost per litre is not yet near dairy. No cost per litre has ever been published.
6. The regulatory milestone that would reprice this company has not happened.The meaningful event in this category is an FDA no questions letter on a GRAS notice. Perfect Day got one in March 2020 (GRN 863) and TurtleTree in May 2025 (GRN 1219). The inventory, updated September 22, 2026, holds no Brown Foods notice and none referencing mammary cell culture. The company’s reported position is self-affirmed GRAS, a decision it makes about itself.

Commercial signals

What to watch

• A first Form D. It would be the first public number attached to this company since 2022.
• A GRAS notice appearing in the FDA inventory, and which letter it draws.
• Whether the first sale is cheese or fluid milk, and at what shelf price.
• Any disclosed volume, titre or cost per litre. Five years of claims contain none.
• Whether more states follow Mississippi before the category has a product on sale.

The Brown Foods story on Healthcare DiscoveryHealthcare Discovery

Related companies

• Anthrogen: Shared investor: Collaborative Fund. A San Francisco lab that set out to engineer carbon-eating bacteria and has become a protein foundation model company, now shipping a 102 billion parameter model called
• XGenomes: Shared investor: Amino Capital. A Cambridge, Massachusetts company reading DNA in five letter words instead of one base at a time
• Jeevam Health: Shared investor: Sri Capital. A Y Combinator backed app that paired functional medicine doctors with Indian thyroid and autoimmune patients, built on the idea that medication alone was not fixing
• Science Exchange: Shared investor: Collaborative Fund. A marketplace for ordering experiments that became procurement software for big pharma, and that sourced the laboratories for the largest public test of whether

Sources

1. Public recordSEC EDGAR company and full text searches for Brown Foods and UnReal MilkSEC · Sep 23, 2026
2. Public recordFDA GRAS Notice Inventory searches, plus GRN 863 and GRN 1219 detail pagesFDA · inventory updated Sep 22, 2026
3. Public recordRecords pull: no FDA 510(k), PMA, registered trial, NIH or NSF award, or PubMed hitCompiled Sep 23, 2026
4. IndependentBrown Foods raises $2.36M for cowless cow’s milkTechCrunch, Christine Hall · Jun 9, 2022
5. IndependentBrief: Cell cultured milk startup Brown Foods raises $2.36m from Y Combinator, AgFunder and othersAgFunderNews, Jennifer Marston · Jun 9, 2022
6. IndependentKunal Shah, Y Combinator Back Dairy Alternatives Startup Brown FoodsInc42 · Jun 10, 2022
7. IndependentCell-cultured UnReal Milk hits U.S. taste buds as FDA shortcut draws ireAGDAILY · Nov 25, 2025
8. IndependentOutrage builds as Franken-milk made in labs prepares to hit storesDaily Mail, Chris Melore · Nov 23, 2025
9. IndependentAfter Cultivated Meat, Mississippi Becomes First US State to Ban Cell-Cultured DairyGreen Queen, Anay Mridul · Mar 30, 2026
10. CompanyThe World’s First Lab-Made Whole Cow Milk is HereGlobeNewswire · Feb 25, 2025
11. InvestorUnReal Milk portfolio pageAgFunder · accessed Sep 2025
12. CompanyBrown Foods company page and UnReal Human Milk launch postY Combinator · accessed Sep 23, 2026

Compiled from SEC, FDA, NIH and NSF public records and published reports as of September 23, 2026. Form D notices report offerings under Regulation D; an issuer that raises under Section 4(a)(2) files none, so the absence of a filing is not evidence that no capital was raised. Healthcare Venture Capital Fund holds no position in Brown Foods. This page is not an offer to sell or a recommendation to buy any security.